Skip to content
2000
Volume 20, Issue 5
  • ISSN: 1573-4129
  • E-ISSN: 1875-676X

Abstract

Background

A combination of fixed-doses containing 0.5 mg lobeglitazone sulfate and 500 mg metformin hydrochloride has demonstrated efficacy in enhancing glycemic control in diabetes.

Aims

The projected work aimed to establish and validate a high-performance thin-layer chromatographic methodology for the quantification of both drugs in tablet formulations.

Objectives

The task involves creating and validating a method in accordance with ICH guidelines to quantify two particular drugs in tablet formulations accurately.

Methods

The high-performance thin-layer chromatographic analysis utilized aluminum plates layered with silica gel 60F, and the solvent system consisted of acetonitrile, 1 M ammonium acetate (methanol), toluene, and triethyl amine (1.5:2.5:4:0.2 v/v/v/v), followed by densitometric scanning at 237 nm.

Results

The methodology exhibited linearity in the range of 100-1500 ng/band for lobeglitazone sulfate and 1000-15000 ng/band for metformin hydrochloride, with correlation coefficients of 0.9991 and 0.9992, correspondingly. Exceptional sensitivity was observed, with detection limits of 8.17 ng/band for lobeglitazone sulfate and 271.34 ng/band for metformin hydrochloride, along with quantification limits of 24.75 ng/band for lobeglitazone sulfate and 822.24 ng/band for metformin hydrochloride. The method demonstrated precision (% relative standard deviation of peak area <2) and accuracy (recovery between 96 and 103%).

Conclusion

The suggested methodology is fit for the concurrent quantification of both drugs in tablet formulations, making it applicable for routine quality control assessments in laboratories.

Loading

Article metrics loading...

/content/journals/cpa/10.2174/0115734129303749240607083542
2024-06-01
2025-01-25
Loading full text...

Full text loading...

References

  1. KahnS.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.Diabetologia200346131910.1007/s00125‑002‑1009‑012637977
    [Google Scholar]
  2. LebovitzH.E. Thiazolidinediones: The forgotten diabetes medications.Curr. Diab. Rep.2019191215110.1007/s11892‑019‑1270‑y31776781
    [Google Scholar]
  3. LehmannJ.M. MooreL.B. Smith-OliverT.A. WilkisonW.O. WillsonT.M. KliewerS.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).J. Biol. Chem.199527022129531295610.1074/jbc.270.22.129537768881
    [Google Scholar]
  4. BaeJ. ParkT. KimH. LeeM. ChaB.S. Lobeglitazone: A novel thiazolidinedione for the management of type 2 diabetes mellitus.Diabetes Metab. J.202145332633610.4093/dmj.2020.027233866775
    [Google Scholar]
  5. Lobeglitazone sulfate.Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Lobeglitazone-sulfate
  6. Indian Pharmacopoeia, Government of India, Ministry of Health & Family WelfareThe Indian Pharmacopoeia CommissionGhaziabad, India2007213581359
    [Google Scholar]
  7. Martindale. The complete drug reference.36 th edPharmaceutical Press (An Imprint of RPS Publishing)London, UK20091453454
    [Google Scholar]
  8. The Merck Index Merck and Co.13th edNJWhite House Station20011061
    [Google Scholar]
  9. SenA.K. PandeyH. MaheshwariR.A. ZanwarA.S. VelmuruganR. SenD.B. Novel UV spectroscopic methods for simultaneous assessment of empagliflozin, linagliptin and metformin in ternary mixture.Ind. J. Pharmac. Educ.Res.2022564ss669s68110.5530/ijper.56.4s.213
    [Google Scholar]
  10. Pharmaceutical composition comprising metformin and lobeglitazone.Patent WO2017073897A12016.Available from:https://patents.google.com/patent/WO2017073897A1/en
  11. Medical Dailogues.Available from: https://medicaldialogues.in/news/industry/pharma/glenmark-gets-cdsco-panel-nod-to-manufacturemarket-lobeglitazone-metformin-antidiabetic-fdc-101532
  12. Medikart pharmacy.Available from: https://www.medkart.in/order-medicine/lobg-m-05500mg-tablet-10s
  13. SenD.B. SenA.K. ZanwarA.S. DashD.K. GreeshmaK.P. AnghamJ. MaheshwariR.A. Novel UV spectrophotometric for the concurrent determination of teneligliptin and metformin in tablet formulation.Res. J. Pharm. Technol.20241731119112710.52711/0974‑360X.2024.00175
    [Google Scholar]
  14. SenD.B. JatuS. MaheshwariR.A. ZanwarA.S. VelmuruganR. SenA.K. New eco-friendly UV-spectroscopic methods for simultaneous assessment of dapagliflozin, saxagliptin and metformin in ternary mixture.Ind. J. Pharmac. Educ. Res.202357255956910.5530/ijper.57.2.69
    [Google Scholar]
  15. SenA.K. GhodasaraS. SenD.B. MaheshwariR.A. ZanwarA.S. DumpalaR.L. Evaluation of remogliflozin, vildagliptin, and metformin in tablet dosage form using modern and cost-effective UV spectroscopic methods.J. Appl. Pharm. Sci.202313912113210.7324/JAPS.2023.136050
    [Google Scholar]
  16. DerakhshanM.S. SohrabiM.R. DavalloM. Developed rapid spectrophotometric method for simultaneous quantitative determination of metformin and linagliptin mixture as antidiabetic drugs by artificial intelligence methodology in biological fluid and pharmaceutical sample.Optik202124116692210.1016/j.ijleo.2021.166922
    [Google Scholar]
  17. DangeY.D. HonmaneS.M. BhingeS.D. SalunkheV.R. JadgeD.R. Development and validation of UV-spectrophotometric method for estimation of metformin in bulk and tablet dosage form.Indian J. Pharmac. Educ. Res.2017514ss754s76010.5530/ijper.51.4s.109
    [Google Scholar]
  18. SenA. HinsuD. SenD. ZanwarA. MaheshwariR. ChandrakarV. Analytical method development and validation for simultaneous estimation of Teneligliptin hydrobromide hydrate and Metformin hydrochloride from it’s pharmaceutical dosage form by three different UV spectrophotometric methods.J. Appl. Pharm. Sci.201660915716510.7324/JAPS.2016.60924
    [Google Scholar]
  19. LotfyH.M. MohamedD. MowakaS. A comparative study of smart spectrophotometric methods for simultaneous determination of sitagliptin phosphate and metformin hydrochloride in their binary mixture.Spectrochim. Acta A Mol. Biomol. Spectrosc.201514944145110.1016/j.saa.2015.04.07625978011
    [Google Scholar]
  20. UmapathiP. AyyappanJ. QuineS.D. Quantitative determination of metformin hydrochloride in tablet formulation containing croscarmellose sodium as disintegrant by HPLC and UV spectrophotometry.Trop. J. Pharm. Res.201211110711610.4314/tjpr.v11i1.14
    [Google Scholar]
  21. GulhaneP.D. JawarkarS.G. Bioanalytical method development and validation for determination of lobeglitazone in human plasma.Int. Res. J.Moderniz. Eng. Technol. Sci.2023558103811610.56726/IRJMETS40687
    [Google Scholar]
  22. SethyK. PadhyG.K. Rajeswari KattaR. A green reversed phase HPLC and HPTLC methods and their validation for simultaneous estimation of remogliflozin, vildgliptin and metformin in fixed dose combination formulation.J. Liq. Chromatogr. Relat. Technol.20232711210.1080/10826076.2023.2284721
    [Google Scholar]
  23. MarieA.A. HammadS.F. SalimM.M. ElkhodaryM.M. KamalA.H. Deduction of the operable design space of RP-HPLC technique for the simultaneous estimation of metformin, pioglitazone, and glimepiride.Sci. Rep.2023131433410.1038/s41598‑023‑30051‑x36928591
    [Google Scholar]
  24. VankalapatiK.R. AlegeteP. BoodidaS. Stability-indicating HPLC method development and validation for simultaneous estimation of metformin, dapagliflozin, and saxagliptin in bulk drug and pharmaceutical dosage form.Biomed. Chromatogr.2022367e538410.1002/bmc.538435434817
    [Google Scholar]
  25. PrajapatiP.B. MistryK.Y. ShahS.A. DoE-based analytical failure modes critical effect analysis (AFMCEA) to a multipurpose-RP-HPLC method for the estimation of multiple FDC products of metformin hydrochloride using an analytical quality by design approach.J. AOAC Int.2022105498699810.1093/jaoacint/qsac02535176154
    [Google Scholar]
  26. PathanM.A. KshirsagarA. Stability indicating HPLC method development and validation for simultaneous estimation of metformin and empagliflozin in bulk and pharmaceutical dosage form.Res.J. Pharm. Technol.202215283083610.52711/0974‑360X.2022.00138
    [Google Scholar]
  27. BhavyasriK SurekhaT BegumS SumakanthM. RP-HPLC method for dapagliflozin and metformin HCL in Bulk and combined formulation.Arch. Pharm. Pract,.202112410611010.51847/Czxl0wYrYr
    [Google Scholar]
  28. MusmadeB.D. BaraskarM.L. GhodkeV.N. BhopeS.G. PadmanabhanS. LoharK.S. Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detector.Future J. Pharmac. Sci.20217121810.1186/s43094‑021‑00362‑9
    [Google Scholar]
  29. KumariK.S. BandhakaviS. Development and validation of stability-indicating RP-HPLC method for the simultaneous determination of ertugliflozin pidolate and metformin hydrochloride in bulk and tablets.Future J. Pharmac. Sci.2020616610.1186/s43094‑020‑00079‑1
    [Google Scholar]
  30. ShakoorA. AhmedM. IkramR. HussainS. TahirA. JanB.M. AdnanA. Stability-indicating RP-HPLC method for simultaneous determination of metformin hydrochloride and vildagliptin in tablet and biological samples.Acta Chromatogr.2020321394310.1556/1326.2019.00555
    [Google Scholar]
  31. GedawyA. Al-SalamiH. DassC.R. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide.J. Food Drug Anal.201927131532210.1016/j.jfda.2018.06.00730648585
    [Google Scholar]
  32. BagadaneS.B. JadhavP.B. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and glipizide in bulk and pharmaceutical dosage form.J. Drug Deliv. Ther.201993-s14615510.22270/jddt.v9i3‑s.2813
    [Google Scholar]
  33. VijayalakshmiB. TatkeP. GabheS. HPLC method development and validation for simultaneous estimation of Metformin and Piperine.Planta Med.2015815PA1810.1055/s‑0035‑1545147
    [Google Scholar]
  34. ChhetriH.P. ThapaP. Van SchepdaelA. Simple HPLC-UV method for the quantification of metformin in human plasma with one step protein precipitation.Saudi Pharm. J.201422548348710.1016/j.jsps.2013.12.01125473337
    [Google Scholar]
  35. ShirodeA. MaduskarP. DeodharM. KadamV. RP-HPLC and HPTLC methods for simultaneous estimation of metformin hydrochloride and vildagliptin from bulk and marketed formulation: Development and validation.Br. J. Pharm. Res.20144202370238610.9734/BJPR/2014/12820
    [Google Scholar]
  36. NirupaG. TripathiU.M. RP-HPLC analytical method development and validation for simultaneous estimation of three drugs: Glimepiride, pioglitazone, and metformin and its pharmaceutical dosage forms.J. Chem.201320131810.1155/2013/726235
    [Google Scholar]
  37. SoniaK. RP-HPLC analysis of metformin hydrochloride and voglibose and study of its different analytical parameter.Int. J. Pharm. Sci. Res.2013441469147410.13040/IJPSR.0975‑8232.4(4).1469‑74
    [Google Scholar]
  38. PanditV. PaiR.S. SinghG. DeviK. NarayanaS. SureshS. Development and validation of the liquid chromatographic method for simultaneous estimation of metformin, pioglitazone, and glimepiride in pharmaceutical dosage forms.Pharm. Methods20123191310.4103/2229‑4708.9770723781471
    [Google Scholar]
  39. ThomasA. PatilS. NandaR. KothapalliL. DeshpandeA. Stability-Indicating RP-HPLC method for determination of metformin hydrochloride and natglinide in bulk and tablet formulations.Curr. Pharm. Anal.20128438138810.2174/157341212803341636
    [Google Scholar]
  40. BhendeS.D. Balaram VaranasiM. AbbuluK. SwethaM.D. ShravanthiV. KumariJ.K. ShayamalaT. RP-HPLC method for the simultaneous estimation of sitagliptin phosphate and metformin hydrochloride in combined ttablet dosage forms.Orient. J. Chem.201228146346910.13005/ojc/280158
    [Google Scholar]
  41. Cristina StengerF. Catia BlockL. CorreaR. Alves de FreitasR. Mari Belle BresolinT. HPLC stability indicating assay method for metformin hydrochloride in bulk drug and tablets and cytotoxicity of degradation products.Curr. Pharm. Anal.20128436837410.2174/157341212803341681
    [Google Scholar]
  42. KarM. ChoudhuryP.K. HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form.Indian J. Pharm. Sci.200971331832010.4103/0250‑474X.5603120490303
    [Google Scholar]
  43. JainD. JainS. JainD. AminM. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride, and glimepiride by RP-HPLC in tablet formulation.J. Chromatogr. Sci.200846650150410.1093/chromsci/46.6.50118647470
    [Google Scholar]
  44. PortaV. SchrammS.G. KanoE.K. KoonoE.E. ArmandoY.P. FukudaK. SerraC.H.R. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies.J. Pharm. Biomed. Anal.200846114314710.1016/j.jpba.2007.10.00718031967
    [Google Scholar]
  45. VichareV.S. ChoudhariV.P. ReddyM.V. Development of new Validated HPTLC Method for simultaneous estimation of Canagliflozin and Metformin in Tablet Formulation.Res. J. Pharm. Technol.20221562599260410.52711/0974‑360X.2022.00434
    [Google Scholar]
  46. BhendeS.D. VaranasiM.B. AbbuluK. A sensitive HPTLC method for the estimation of glibenclamide, rosiglitazone maleate and metformin hydrochloride from a multicomponent dosage form.J. Chromatogr. Sci.202058541842610.1093/chromsci/bmz12432086517
    [Google Scholar]
  47. AbdelrahmanA.E. MaherH.M. AlzomanN.Z. HPTLC method for the determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceuticals.Curr. Anal. Chem.202016560961910.2174/1573407215666190131123029
    [Google Scholar]
  48. ChaudhariP.; Patil, P.; Mahajan, S.; Patil, P. HPTLC–Stability Indicating Densitometric Method for Determination of Metformin Hydrochloride in Tablet FormulationCurr. Pharm. Res.2019932970298010.33786/JCPR.2019.v09i03.016
    [Google Scholar]
  49. SakhareR.S. PekamwarS.S. MohkareD.P. Development and validation of stability indicating HPTLC method for the determination of metformin hydrochloride and benfotiamine in bulk and combined dosage form.Ind. J. Pharmac. Educ. Res.2017512ss8s1610.5530/ijper.51.2s.44
    [Google Scholar]
  50. RankM. KapuparaP. ShahK. Development and validation of stability indicating HPTLC method for pioglitazone hydrochloride and metformin hydrochloride.Res. J. Pharm. Technol.20169101555156110.5958/0974‑360X.2016.00305.X
    [Google Scholar]
  51. El-KimaryE.I. HamdyD.A. MouradS.S. BararyM.A. HPTLC determination of three gliptins in binary mixtures with metformin.J. Chromatogr. Sci.2015541bmv10610.1093/chromsci/bmv10626223462
    [Google Scholar]
  52. PatelK.K. KarkhanisV.V. GajjarS.S. Development and validation of stability indicating HPTLC method for estimation of glimepiride and metformin hydrochloride.Int. J. Pharm. Sci. Res.2015631222122910.13040/IJPSR.0975‑8232.6(3).1222‑29
    [Google Scholar]
  53. ModiD.K. ParejiyaP.B. PatelB.H. A simple and sensitive HPTLC method for simultaneous determination of metformin hydrochloride and sitagliptin phosphate in tablet dosage form.J. Chem.201320131410.1155/2013/139561
    [Google Scholar]
  54. ModiD.K. PatelB.H. Simultaneous determination of metformin hydrochloride and glipizide in tablet formulation by HPTLC.J. Liq. Chromatogr. Relat. Technol.2012351283910.1080/10826076.2011.593227
    [Google Scholar]
  55. ThomasA.B. PatilS.D. NandaR.K. KothapalliL.P. BhosleS.S. DeshpandeA.D. Stability-indicating HPTLC method for simultaneous determination of nateglinide and metformin hydrochloride in pharmaceutical dosage form.Saudi Pharm. J.201119422123110.1016/j.jsps.2011.06.00523960763
    [Google Scholar]
  56. HaveleS. DhaneshwarS. Estimation of metformin in bulk drug and in formulation by HPTLC.J. Nanomed. Nanotechnol.201011100010210.4172/2157‑7439.1000102
    [Google Scholar]
  57. GhassempourA. AhmadiM. EbrahimiS.N. Aboul-EneinH.Y. Simultaneous determination of metformin and glyburide in tablets by HPTLC.Chromatographia2006641-210110410.1365/s10337‑006‑0827‑5
    [Google Scholar]
  58. WattamwarT. MungantiwarA. GujarS. PanditaN. Development of LC-MS/MS method for simultaneous determination of Canagliflozin and Metformin in human plasma and its pharmacokinetic application in Indian population under fast and fed conditions.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2020115412228110.1016/j.jchromb.2020.12228132763846
    [Google Scholar]
  59. MohamedD. ElshahedM.S. NasrT. AboutalebN. ZakariaO. Novel LC–MS/MS method for analysis of metformin and canagliflozin in human plasma: Application to a pharmacokinetic study.BMC Chem.20191318210.1186/s13065‑019‑0597‑431384829
    [Google Scholar]
  60. AyoubB.M. MowakaS. LC–MS/MS determination of empagliflozin and metformin.J. Chromatogr. Sci.201755774274710.1093/chromsci/bmx03028383657
    [Google Scholar]
  61. KimB. ShinH.S. KimJ.R. LimK.S. YoonS.H. YuK.S. ShinS.G. JangI.J. ChoJ.Y. Quantitative and qualitative analysis of CKD-501, lobeglitazone, in human plasma and urine using LC–MS/MS and its application to a pharmacokinetic study.Chromatographia20127511-1267167710.1007/s10337‑012‑2238‑0
    [Google Scholar]
  62. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of analytical procedures: text and methodology Q2(R1).GenevaICH2005Available from: https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf
    [Google Scholar]
  63. SrivastavaM.M. An overview of HPTLC: A modern analytical technique with excellent potential for automation, optimization, hyphenation, and multidimensional applications.High-Performance Thin-Layer Chromatography (HPTLC). SrivastavaM. Berlin, HeidelbergSpringer201132410.1007/978‑3‑642‑14025‑9_1
    [Google Scholar]
  64. AttimaradM. Mueen AhmedK.K. AldhubaibB.E. HarshaS. High-performance thin layer chromatography: A powerful analytical technique in pharmaceutical drug discovery.Pharm. Methods201122717510.4103/2229‑4708.8443623781433
    [Google Scholar]
  65. PrajapatiP. RadadiyaK. ShahS. Principal component analysis and DoE-based AQbD approach to multipurpose HPTLC method for synchronous estimation of multiple FDCs of metformin HCl, repaglinide, glibenclamide and pioglitazone HCl.J. Chromatogr. Sci.202462210811910.1093/chromsci/bmac05535797718
    [Google Scholar]
  66. KoradiaS. PatelM. SenA.K. SenD.B. PradhanP. Analytical quality by design-based thin-layer chromatography method development and validation for assay and content uniformity testing of the anti-neoplastic drug Axitinib in tablet formulation.Separ. Sci. Plus202473230017610.1002/sscp.202300176
    [Google Scholar]
  67. SenA.K. KhatariyaS.B. SenD.B. MaheshwariR.A. AkabariA.H. VelmuruganR. Development and validation of high-performance thin layer chromatographic method for concurrent estimation of dapagliflozin and vildagliptin in combined tablet.Separ. Sci. Plus202471230013210.1002/sscp.202300132
    [Google Scholar]
  68. SenA.K. BhimaniN. SenD.B. MaheshwariR.A. GohilD. KoradiaS.K. Densitometric simultaneous assessment of teneligliptin hydrobromide and pioglitazone hydrochloride in combined tablet.Separ. Sci. Plus202471230013910.1002/sscp.202300139
    [Google Scholar]
  69. AkabariA.H. SuratiJ. PatelS. PathakB. PatelA. PatelC. PatelS.K. Development and validation of high-performance thin layer chromatographic method for simultaneous quantitation of novel combination perindopril erbumine and moxonidine hydrochloride.Separ. Sci. Plus202369230005110.1002/sscp.202300051
    [Google Scholar]
  70. SuratiJ. KaleshK. AkbariA. PatelS. ShahK. SolankiD. Validated thin-layer chromatographic–densitometric and high-performance liquid chromatographic methods for the simultaneous determination of alfuzosin and tadalafil in pharmaceutical products.J. Planar Chromatogr. Mod. TLC2023362-313714610.1007/s00764‑023‑00240‑5
    [Google Scholar]
  71. Abou El-AlaminM.M. ToubarS.S. MohamedD.A. HelmyM.I. Development of Green HPTLC method for simultaneous determination of a promising combination Tamsulosin and Mirabegron: stability-indicating assay was examined.BMC Chem.202317113010.1186/s13065‑023‑01043‑937777770
    [Google Scholar]
  72. PrajapatiP. TailorP. ShahiA. AcharyaA. ShahS. Application of chemometry and design of experiments to green HPTLC method for synchronous estimation of multiple FDCs of cilnidipine.J. AOAC Int.202210551491150110.1093/jaoacint/qsac05635543467
    [Google Scholar]
  73. KumssaL. LayloffT. HymeteA. AshenefA. High performance thin layer chromatography (HPTLC) method development and validation for determination of doxycycline hyclate in capsule and tablet formulations.Acta Chromatogr.202234328729510.1556/1326.2021.00926
    [Google Scholar]
  74. ShahD.A. PatelP.A. ChhalotiyaU. Thin-layer chromatographic‒densitometric method of analysis for the estimation of montelukast and bilastine in combination.J. Planar Chromatogr. Mod. TLC202134428929510.1007/s00764‑021‑00120‑w
    [Google Scholar]
  75. ShahP. PatelJ. PatelK. GandhiT. Development and validation of an HPTLC method for the simultaneous estimation of Clonazepam and Paroxetine hydrochloride using a DOE approach.J. Taibah Univ. Sci.201711112113210.1016/j.jtusci.2015.11.004
    [Google Scholar]
/content/journals/cpa/10.2174/0115734129303749240607083542
Loading
/content/journals/cpa/10.2174/0115734129303749240607083542
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test